Treatment of bioresorbable scaffold failure.


Bioresorbable scaffolds (BRS) are a promising new interventional treatment strategy for coronary artery disease (CAD). They are intended to overcome some of the shortcomings of metal drug-eluting stents (DES), mainly late reinterventions which occur at a consistent rate after one year and have not been reduced by the use of local drug elution. Initial… (More)
DOI: 10.4244/EIJV11SVA42


6 Figures and Tables